Bladder cancer TURB
In this UROwebinar through a series of debates and troubleshooting challenges, participants will expand their knowledge on the pathology and molecular landscape of non-muscle-invasive bladder cancer (NMIBC) and its treatment consequences.
| Organiser | European School of Urology |
|---|---|
| CME | 1 |
| Duration | Approx. 60 – 90 minutes |
Participants will receive updates on the diagnostics and staging of bladder cancer (BCa). They will discover more about NMIBC, specifically endoscopic diagnosis and therapy, treatment optimisation, the role of local and new systemic approaches and their optimal timing.
Additionally, participants will become more familiar with the evaluation of quality of life coming along with the bladder-sparing approach with regard to muscle-invasive bladder cancer (MIBC).
The speakers will also provide expert insights on systemic and intravesical therapy in metastatic bladder and urothelial cancer, as well as, BCa recurrence and follow-up. As part of the webinar the speakers will debate and trouble shoot current challenges around TURB l